Assyro AI

Orange Book product · Brand (NDA)

OMONTYS

PEGINESATIDE ACETATE

Brand (NDA)NDA 202799DISCN TAKEDA PHARMS USA

At a glance

Mar 27, 2012

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 27, 2012

    14 yr 5 mo ago

  2. Patent 7550433 expires

    Listed method-of-use patent (U-1238) expiration.

    Jun 02, 2026

    17 d ago

  3. Patent 7919461 expires

    Listed method-of-use patent (U-1238) expiration.

    Jun 02, 2026

    17 d ago

  4. Today

Pharmaceutical detail

Active ingredient

PEGINESATIDE ACETATE

Strength

EQ 10MG BASE/ML (EQ 10MG BASE/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS, SUBCUTANEOUS

TE code

Not listed

Application

NDA 202799

Product number

007

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7550433Jun 02, 202617 d ago
U-1238
7919461Jun 02, 202617 d ago
U-1238
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.